402 related articles for article (PubMed ID: 31350093)
21. An Erythrocytosis-Associated Mutation in the Zinc Finger of PHD2 Provides Insights into Its Binding of p23.
Song D; Guan W; Coon LM; Al-Kali A; Oliveira JL; Lee FS
Hypoxia (Auckl); 2019; 7():81-86. PubMed ID: 31853455
[TBL] [Abstract][Full Text] [Related]
22. Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma.
Wiesener MS; Seyfarth M; Warnecke C; Jürgensen JS; Rosenberger C; Morgan NV; Maher ER; Frei U; Eckardt KU
Blood; 2002 May; 99(10):3562-5. PubMed ID: 11986208
[TBL] [Abstract][Full Text] [Related]
23. Inactivation of HIF-prolyl 4-hydroxylases 1, 2 and 3 in NG2-expressing cells induces HIF2-mediated neurovascular expansion independent of erythropoietin.
Urrutia AA; Guan N; Mesa-Ciller C; Afzal A; Davidoff O; Haase VH
Acta Physiol (Oxf); 2021 Jan; 231(1):e13547. PubMed ID: 32846048
[TBL] [Abstract][Full Text] [Related]
24. Notch Downregulation and Extramedullary Erythrocytosis in Hypoxia-Inducible Factor Prolyl 4-Hydroxylase 2-Deficient Mice.
Myllymäki MNM; Määttä J; Dimova EY; Izzi V; Väisänen T; Myllyharju J; Koivunen P; Serpi R
Mol Cell Biol; 2017 Jan; 37(2):. PubMed ID: 27821476
[TBL] [Abstract][Full Text] [Related]
25. Mutations in the VHL gene in sporadic apparently congenital polycythemia.
Pastore YD; Jelinek J; Ang S; Guan Y; Liu E; Jedlickova K; Krishnamurti L; Prchal JT
Blood; 2003 Feb; 101(4):1591-5. PubMed ID: 12393546
[TBL] [Abstract][Full Text] [Related]
26. A novel biological function of soluble biglycan: Induction of erythropoietin production and polycythemia.
Frey H; Moreth K; Hsieh LT; Zeng-Brouwers J; Rathkolb B; Fuchs H; Gailus-Durner V; Iozzo RV; de Angelis MH; Schaefer L
Glycoconj J; 2017 Jun; 34(3):393-404. PubMed ID: 27600268
[TBL] [Abstract][Full Text] [Related]
27. Disturbance in the HIF-1alpha pathway associated with erythrocytosis: further evidences brought by frameshift and nonsense mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene.
Al-Sheikh M; Moradkhani K; Lopez M; Wajcman H; Préhu C
Blood Cells Mol Dis; 2008; 40(2):160-5. PubMed ID: 17933562
[TBL] [Abstract][Full Text] [Related]
28. HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis.
Franke K; Kalucka J; Mamlouk S; Singh RP; Muschter A; Weidemann A; Iyengar V; Jahn S; Wieczorek K; Geiger K; Muders M; Sykes AM; Poitz DM; Ripich T; Otto T; Bergmann S; Breier G; Baretton G; Fong GH; Greaves DR; Bornstein S; Chavakis T; Fandrey J; Gassmann M; Wielockx B
Blood; 2013 Feb; 121(8):1436-45. PubMed ID: 23264599
[TBL] [Abstract][Full Text] [Related]
29. Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia.
Ladroue C; Hoogewijs D; Gad S; Carcenac R; Storti F; Barrois M; Gimenez-Roqueplo AP; Leporrier M; Casadevall N; Hermine O; Kiladjian JJ; Baruchel A; Fakhoury F; Bressac-de Paillerets B; Feunteun J; Mazure N; Pouysségur J; Wenger RH; Richard S; Gardie B
Haematologica; 2012 Jan; 97(1):9-14. PubMed ID: 21933857
[TBL] [Abstract][Full Text] [Related]
30. Integrity of the prolyl hydroxylase domain protein 2:erythropoietin pathway in aging mice.
Li X; Sutherland S; Takeda K; Fong GH; Lee FS
Blood Cells Mol Dis; 2010 Jun; 45(1):9-19. PubMed ID: 20400342
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo.
Rankin EB; Biju MP; Liu Q; Unger TL; Rha J; Johnson RS; Simon MC; Keith B; Haase VH
J Clin Invest; 2007 Apr; 117(4):1068-77. PubMed ID: 17404621
[TBL] [Abstract][Full Text] [Related]
32. HIF pathway mutations and erythrocytosis.
McMullin MF
Expert Rev Hematol; 2010 Feb; 3(1):93-101. PubMed ID: 21082936
[TBL] [Abstract][Full Text] [Related]
33. A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2
Pang Y; Gupta G; Yang C; Wang H; Huynh TT; Abdullaev Z; Pack SD; Percy MJ; Lappin TRJ; Zhuang Z; Pacak K
BMC Cancer; 2018 Mar; 18(1):286. PubMed ID: 29534684
[TBL] [Abstract][Full Text] [Related]
34. Prolyl-4-Hydroxylase 2 Potentially Contributes to Hepatocellular Carcinoma-Associated Erythrocytosis by Maintaining Hepatocyte Nuclear Factor-4α Expression.
Sun W; Kosyna FK; Jelkmann W; Depping R
Cell Physiol Biochem; 2015; 37(6):2257-64. PubMed ID: 26624507
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic inhibition of HIF-2α reverses polycythemia and pulmonary hypertension in murine models of human diseases.
Ghosh MC; Zhang DL; Ollivierre WH; Noguchi A; Springer DA; Linehan WM; Rouault TA
Blood; 2021 May; 137(18):2509-2519. PubMed ID: 33512384
[TBL] [Abstract][Full Text] [Related]
36. Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia.
Yang C; Zhuang Z; Fliedner SM; Shankavaram U; Sun MG; Bullova P; Zhu R; Elkahloun AG; Kourlas PJ; Merino M; Kebebew E; Pacak K
J Mol Med (Berl); 2015 Jan; 93(1):93-104. PubMed ID: 25263965
[TBL] [Abstract][Full Text] [Related]
37. "Benign erythrocytosis" and other familial and congenital polycythemias.
Prchal JT; Sokol L
Eur J Haematol; 1996 Oct; 57(4):263-8. PubMed ID: 8982288
[TBL] [Abstract][Full Text] [Related]
38. Increased EPO Levels Are Associated With Bone Loss in Mice Lacking PHD2 in EPO-Producing Cells.
Rauner M; Franke K; Murray M; Singh RP; Hiram-Bab S; Platzbecker U; Gassmann M; Socolovsky M; Neumann D; Gabet Y; Chavakis T; Hofbauer LC; Wielockx B
J Bone Miner Res; 2016 Oct; 31(10):1877-1887. PubMed ID: 27082941
[TBL] [Abstract][Full Text] [Related]
39. Genetically heterogeneous origins of idiopathic erythrocytosis.
Percy MJ
Hematology; 2007 Apr; 12(2):131-9. PubMed ID: 17454194
[TBL] [Abstract][Full Text] [Related]
40. A common polymorphism in the oxygen-dependent degradation (ODD) domain of hypoxia inducible factor-1alpha (HIF-1alpha) does not impair Pro-564 hydroxylation.
Percy MJ; Mooney SM; McMullin MF; Flores A; Lappin TR; Lee FS
Mol Cancer; 2003 Sep; 2():31. PubMed ID: 14521712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
